XOMAP Q2 2022 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$983,000+9.1% YoY

Gross Profit

$943,00095.9% margin

Operating Income

-$5M-484.9% margin

Net Income

-$5M-475.1% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

-68.4%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$154M

Total Liabilities

$19M

Stockholders' Equity

$135M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$983,000	$901,000	+9.1%
Gross Profit	$943,000	$863,000	+9.3%
Operating Income	-$5M	-$3M	-55.6%
Net Income	-$5M	-$2M	-108.8%